An Evaluation Of Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) Prospects

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.

Stocks Info

AMLX belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Amylyx Pharmaceuticals Inc is $257.93M. A total of 1.71 million shares were traded on the day, compared to an average of 809.05K shares.

Insider Activity

Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, AMLX has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 0 SELLs from insiders. Insiders purchased 0 shares during that period but sold 0.

In the most recent transaction, Mazzariello Gina sold 4,169 shares of AMLX for 3.15 per share on Feb 24 ’25. After the transaction, the Chief Legal Officer now owns 134,921 company shares. In a previous transaction on Feb 03 ’25, Mazzariello Gina sold 3,678 shares at 3.49 per share. AMLX shares that Chief Legal Officer owns now total 139,090.

Among the insiders who sold shares, Cohen Joshua B disposed of 11,851 shares on Feb 03 ’25 at a per-share price of $3.47. This resulted in the Co-Chief Executive Officer holding 3,201,247 shares of AMLX after the transaction. In another insider transaction, Klee Justin B. sold 11,855 shares at $3.47 per share on Feb 03 ’25. Company shares held by the Co-Chief Executive Officer now total 3,164,933.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for AMLX in the last 3 months, the mean price target is $9.00 with high estimates of $12.00 and low estimates of $4.00. In terms of 52-week highs and lows, AMLX has a high of $19.42 and a low of $1.58.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. AMLX’s latest balance sheet shows that the firm has $96.12M in Cash & Short Term Investments as of fiscal 2021. There were $0.00 in debt and $17.40M in liabilities at the time. Its Book Value Per Share was $2.86, while its Total Shareholder’s Equity was -$151.17M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AMLX is Buy with a score of 3.86.

Most Popular

Related Posts